OMNOVA Solutions Inc. (NYSE:OMN) shares increased 0.83% in last trading session and ended the day at $4.87. OMN Gross Margin is 22.10% and its has a return on assets of 0.90%. OMNOVA Solutions Inc. (NYSE:OMN) quarterly performance is -31.89%.
New Oriental Education & Technology Group Inc. (NYSE:EDU) ended the last trading day at $28.87. Company weekly volatility is calculated as 3.75% and price to cash ratio as 3.43. New Oriental Education & Technology Group Inc. (NYSE:EDU) showed a weekly performance of 2.70%.
On 19 January, Omnova Solutions Inc. (NYSE:OMN) reported a fiscal fourth-quarter loss of $18.9 million, after reporting a profit in the same period a year earlier. The Beachwood, Ohio-based company said it had a loss of 43 cents per share. Earnings, adjusted for one-time gains and costs, were 13 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share.
New Oriental Education & Technology Group Inc (NYSE:EDU) reported net revenues of US$278.1 million, representing a 17.7% increase year-over-year. Net revenues from educational programs and services for the second fiscal quarter were US$251.5 million, representing an 18.7% increase year-over-year. The growth was mainly driven by increases in student enrollments in K-12 after-school tutoring courses. Total student enrollments in academic subjects tutoring and test preparation courses in the second fiscal quarter of 2016 increased by 35.3% year-over-year to approximately 841,000.
On 21 January, Morgan Stanley (NYSE:MS) shares decreased -1.82% and was closed at $24.78. MS EPS growth in last 5 year was 32.90%. Morgan Stanley (NYSE:MS) year to date (YTD) performance is -22.10%.
Morgan Stanley (NYSE:MS) reported net revenues of $7.7 billion for the fourth quarter ended December 31, 2015 compared with $7.8 billion a year ago. For the current quarter, net income applicable to Morgan Stanley was $908 million, or $0.39 per diluted share, compared with net losses of $1.6 billion, or $0.91 per diluted share, for the same period a year ago. The prior year quarter included several significant items which aggregated to a net loss of $1.37 per diluted share.
Neuralstem, Inc. (NASDAQ:CUR) shares moved up 9.52% in last trading session and ended the day at $0.65. CUR has a return on assets of -79.90%. Neuralstem, Inc. (NASDAQ:CUR) quarterly performance is -46.28%.
On 11 January, Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced publication of “Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-1: A Novel Cellular Therapy for Alzheimer’s Disease,” in Stem Cells Translational Medicine.
CTI BioPharma Corp. (NASDAQ:CTIC) caters to the Healthcare space. Its weekly performance is -4.24%. On the last day of trading company shares ended up at $1.13. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is -4.75%.
On 13 January, CTI BioPharma Corp. (NASDAQ: CTIC) announced that Matthew Perry, President of BVF Partners L.P. (BVF Partners) and CTI BioPharma’s largest shareholder, has been appointed to the Board of Directors of CTI BioPharma.
Leave a Reply